DT-diaphorase Protects Against Autophagy Induced by Aminochrome-Dependent Alpha-Synuclein Oligomers. (Q38704492)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28478529%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

DT-diaphorase Protects Against Autophagy Induced by Aminochrome-Dependent Alpha-Synuclein Oligomers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28478529%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28478529%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Patricia S Muñoz

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28478529%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

6 May 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28478529%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

published in

Neurotoxicity Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28478529%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28478529%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28478529%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

362-367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28478529%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12640-017-9747-4

19 March 2020

exact match

0 references

cites work

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Dopamine quinones interact with alpha-synuclein to form unstructured adducts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Autophagy and aging: keeping that old broom working

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Aggregated Alpha-Synuclein Transfer Efficiently between Cultured Human Neuron-Like Cells and Localize to Lysosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Alpha-synuclein structure, functions, and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Alpha-Synuclein Oligomers-Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Neurodegenerative disease: amyloid pores from pathogenic mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Endoproteolytic activity of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Stable expression of short interfering RNA for DT-diaphorase induces neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Lysosomal degradation of alpha-synuclein in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Overexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

DT-Diaphorase Prevents Aminochrome-Induced Alpha-Synuclein Oligomer Formation and Neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Optical reporters for the conformation of alpha-synuclein reveal a specific interaction with mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

The catecholaminergic RCSN-3 cell line: a model to study dopamine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Autophagy protects against aminochrome-induced cell death in substantia nigra-derived cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Phenotypic spectrum of alpha-synuclein mutations: New insights from patients and cellular models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Protective and toxic roles of dopamine in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Aminochrome as New Preclinical Model to Find New Pharmacological Treatment that Stop the Development of Parkinson's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Comparison of structure and dynamics of micelle-bound human alpha-synuclein and Parkinson disease variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

α-Synuclein and protein degradation systems: a reciprocal relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9747-4

Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase.

21 January 2018

1 reference

12 December 2020

A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition

1 reference

12 December 2020

1 reference

12 December 2020

Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments

1 reference

12 December 2020

Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?

1 reference

12 December 2020

Intranasal administration of alpha-synuclein aggregates: a Parkinson's disease model with behavioral and neurochemical correlates

1 reference

12 December 2020